Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Optrex Sore Eye Drops

Active Ingredient:
Company:  
Reckitt Benckiser Healthcare (UK) Ltd See contact details
About Medicine
{healthcare_pro_orange} This information is for use by healthcare professionals
Last updated on emc: 21 Jul 2017
1. Name of the medicinal product

Optrex Sore Eye Drops

2. Qualitative and quantitative composition

Active

Distilled Witch Hazel BPC l3%v/v

(Synonyms: Hamamelis Water, Witch Hazel)

3. Pharmaceutical form

Eye Drops

4. Clinical particulars
4.1 Therapeutic indications

For the relief of minor eye irritations caused by dusty or smoky atmospheres, driving or close work.

4.2 Posology and method of administration

For topical application into the eye.

For adults, children and the elderly:

Gently squeeze one or two drops into each eye.

Use as often as required.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

For external use only.

Not suitable for use with hydrophilic (soft) contact lenses.

Keep all medicines out of the sight and reach of children.

Discard any eye drops remaining 28 days after opening the container.

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant drug interactions known.

4.6 Pregnancy and lactation

The safety of Optrex Sore Eyes Eye Drops during pregnancy and lactation has not been established but use during these periods is not considered to constitute a hazard.

4.7 Effects on ability to drive and use machines

No adverse effects known.

4.8 Undesirable effects

Occasional hypersensitivity reactions.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

4.9 Overdose

In view of the size of the container, overdosage should not be a problem and any treatment should only be symptomatic.

5. Pharmalogical Properties

5. Pharmacological properties
5.1 Pharmacodynamic properties

Hamamelis water has cooling and astringent properties.

5.2 Pharmacokinetic properties

Not available.

5.3 Preclinical safety data

There are no preclinical safety data of relevance to the consumer.

6. Pharmaceutical particulars
6.1 List of excipients

Boric acid

Borax

Glycerin

Benzalkonium chloride

Purified water

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

a)

Unopened:

36 months

b)

After first opening:

28 days

6.4 Special precautions for storage

Store below 25° C.

6.5 Nature and contents of container

Polyethylene bottle with a polyethylene dropper plug and a tamper evident polyethylene cap. Pack sizes of 10ml and 18ml.

6.6 Special precautions for disposal and other handling

None.

7. Marketing authorisation holder

Optrex Limited

103-105 Bath Road

Slough

SL1 3UH

UK

8. Marketing authorisation number(s)

PL 00062/5003R

9. Date of first authorisation/renewal of the authorisation

15 May 1987

10. Date of revision of the text

30/06/2017

Reckitt Benckiser Healthcare (UK) Ltd
Company image
Address
RB Consumer Relations, PO Box 4644, SLOUGH, SL1 0NS, UK
Telephone
0333 2005 345
Medical Information Direct Line
0333 2005 345
Customer Care direct line
0333 2005 345